Case Report

ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS

Volume: 14 Number: 3 May 31, 2024
TR EN

ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS

Abstract

Ichthyosis is a heterogeneous group of conification disorders characterized by hyperkeratosis involving the skin. One form of ichthyosis, lamellar ichthyosis (LI), is autosomal recessively inherited with an incidence of 1/300,000. The diagnosis is based on clinical findings, skin biopsy and genetic analysis. Treatment includes moisturizing the skin, reducing fluid loss and keratolytics. Oral retinoids have been found to be very successful in the treatment of LI(1). In this case, a premature newborn diagnosed with LI is presented because of its rarity and good response to oral retinoid treatment.

Keywords

Supporting Institution

yok

References

  1. 1. Fischer J, Bourrat E. Genetics of Inherited Ichthyoses and Related Diseases. Acta Derm Venereol. 2020 ; 100(7):186-196.
  2. 2. Morelli JG. Disorders of keratinization. in: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds). Nelson Textbook of Pediatrics. 18th edPhiladelphia: WB Sounders Company; 2007.p.2708-2714.
  3. 3 . Tekin M, Konca Ç, Kahramaner Z, ErdemirA. Harlequin iktiyozis: Aynı ailede üçüncü olgu. Türk Ped Arş 2014; 49: 269-71.
  4. 4. Soyuer U, Kurtoğlu S, Aktaş E, Hasanoğlu E. Hypernatremia in two collodion babies. Turk J Pediatr 1989; 31: 173-5.
  5. 5. Shibata, A. & Akiyama, M. Epidemiology, medical genetics, diagnosis and treatment of harlequin ichthyosis in Japan. Pediatr. Int. 2015;57, 516–22.
  6. 6. Lilly E, Bunick CG. Congenital Ichthyosis: A Practical Clinical Guide on Current Treatments and Future Perspectives. Clin Cosmet Investig Dermatol. 2023 ;11;16:2473-79.

Details

Primary Language

English

Subjects

Dermatology

Journal Section

Case Report

Early Pub Date

May 19, 2024

Publication Date

May 31, 2024

Submission Date

May 6, 2024

Acceptance Date

May 17, 2024

Published in Issue

Year 2024 Volume: 14 Number: 3

APA
Sivas, H. M. (2024). ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS. Journal of Contemporary Medicine, 14(3), 158-159. https://doi.org/10.16899/jcm.1478881
AMA
1.Sivas HM. ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS. J Contemp Med. 2024;14(3):158-159. doi:10.16899/jcm.1478881
Chicago
Sivas, Hanife Merve. 2024. “ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS”. Journal of Contemporary Medicine 14 (3): 158-59. https://doi.org/10.16899/jcm.1478881.
EndNote
Sivas HM (May 1, 2024) ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS. Journal of Contemporary Medicine 14 3 158–159.
IEEE
[1]H. M. Sivas, “ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS”, J Contemp Med, vol. 14, no. 3, pp. 158–159, May 2024, doi: 10.16899/jcm.1478881.
ISNAD
Sivas, Hanife Merve. “ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS”. Journal of Contemporary Medicine 14/3 (May 1, 2024): 158-159. https://doi.org/10.16899/jcm.1478881.
JAMA
1.Sivas HM. ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS. J Contemp Med. 2024;14:158–159.
MLA
Sivas, Hanife Merve. “ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS”. Journal of Contemporary Medicine, vol. 14, no. 3, May 2024, pp. 158-9, doi:10.16899/jcm.1478881.
Vancouver
1.Hanife Merve Sivas. ORAL RETINOID TREATMENT IN A NEWBORN WITH LAMELLAR ICHTHYOSIS. J Contemp Med. 2024 May 1;14(3):158-9. doi:10.16899/jcm.1478881